Relay Therapeutics, Inc. Deferred Tax Assets, Operating Loss Carryforwards, State and Local
Relay Therapeutics, Inc. (RLAY) had Deferred Tax Assets, Operating Loss Carryforwards, State and Local of $625.60 million as of 2025-12-31, per its 10-K filed 2026-02-26.
Financial Statements › Notes › Income Taxes › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross › Deferred Tax Assets, Operating Loss Carryforwards, Components
us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal · last filed 2026-02-26
- 2025-12-31: Deferred Tax Assets, Operating Loss Carryforwards, State and Local $625.60M.
- 2024-12-31: Deferred Tax Assets, Operating Loss Carryforwards, State and Local $625.20M.
- 2023-12-31: Deferred Tax Assets, Operating Loss Carryforwards, State and Local $559.70M.
- 2022-12-31: Deferred Tax Assets, Operating Loss Carryforwards, State and Local $501.70M.
| Period end | Deferred Tax Assets, Operating Loss Carryforwards, State and Local | Deferred Tax Assets, Operating Loss Carryforwards, State and Local as first filed |
|---|---|---|
| 2025-12-31 | $625.60M 10-K · filed 2026-02-26 | |
| 2024-12-31 | $625.20M 10-K · filed 2026-02-26 | |
| 2023-12-31 | $559.70M 10-K · filed 2025-02-26 | |
| 2022-12-31 | $501.70M 10-K · filed 2024-02-22 | |
| 2021-12-31 | $466.20M 10-K · filed 2023-02-23 | |
| 2020-12-31 | $192.30M 10-K · filed 2022-02-24 | $192.35M 10-K · filed 2021-03-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tarsus Pharmaceuticals, Inc. (TARS) | United States | $3.329B | -58.60 |
| Denali Therapeutics Inc. (DNLI) | United States | $3.274B | -8.04 |
| Adaptive Biotechnologies Corp (ADPT) | United States | $4.719B | -53.43 |
| IOVANCE BIOTHERAPEUTICS, INC. (IOVA) | United States | $4.897B | -6.51 |
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| CRISPR Therapeutics AG (CRSP) | $5.390B | -11.68 | |
| Greenland Mines Ltd (GRML) | United States | $2.362B | |
| BIOCRYST PHARMACEUTICALS INC (BCRX) | United States | $2.175B | -6.63 |
| ADMA BIOLOGICS, INC. (ADMA) | United States | $2.131B | 11.16 |
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |